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ABSTRACT
Introduction: Corpus callosum agenesis (ACC) is frequently diagnosed during fetal life; its 
prognosis depends also on additional anomalies. The additional value of fetal magnetic resonance 
imaging (MRI) in fetuses with ‘isolated’ complete (cACC) and partial (pACC) agenesis of the 
corpus callosum on ultrasound is still debated. Material and Methods: We performed a 
systematic literature review and meta-analysis including fetuses with a prenatal diagnosis of 
cACC and pACC without associated structural anomalies on ultrasound, undergoing fetal MRI. 
The primary outcome was the rate of additional anomalies detected at fetal MRI. Further analyses 
assessed the effect of type of ultrasound assessment (neurosonography vs standard axial 
assessment), gestational age at fetal MRI, rate of postnatally detected brain anomalies. Random-
effect meta-analyses of proportions were used to analyze the data. Results: Fourteen studies (798 
fetuses) were included. In cases with isolated cACC, 10.9%(95% CI 4.1-20.6) and 4.3% (95% CI 
1.4-8.8) additional anomalies were detected by fetal MRI and postnatally respectively. Stratifying 
according to the type of ultrasound assessment, the rate of associated anomalies detected only on 
fetal MRI was 5.7% (95% CI 0.5-16.0) with dedicated neurosonography and 18.5% (95% CI 7.8-
32.4) with a standard axial assessment. In fetuses with isolated pACC, 13.4% (95% CI 4.0-27-0) 
and 16.2% (95% CI 5.9-30-3) additional anomalies were detected by fetal MRI or postnatally 
respectively. Stratifying according to the type of ultrasound assessment, the rate of associated 
anomalies detected only on fetal MRI was 11.4% (95% CI 2.7-25-0) when dedicated 
neurosonography was performed. Cortical and posterior fossa anomalies represented the most 
common anomalies missed at ultrasound with both cACC and pACC. Due the very small number 
of included cases, stratification according to early (<24 weeks of gestation) and late (>24 weeks) 
fetal MRI couldn't be done either for cACC or pACC. Conclusions: The rate of associated 
anomalies detected exclusively at fetal MRI in isolated ACC undergoing neurosonography is 
lower compared to what previously reported. Cortical and posterior fossa anomalies are among the 
most common anomalies detected exclusively at MRI, thus confirming the crucial role of fetal 
MRI in determining the prognosis of these fetuses. However, some anomalies still go undetected 
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cACC: complete agenesis of corpus callosum
pACC: partial agenesis of corpus callosum;
ACC: agenesis of corpus callosum;
CNS: central nervous system
ISUOG International Society of Ultrasound in Obstetrics & Gynecology
NOS Newcastle-Ottawa Scale 
OR  odds ratio 
Key Message:
The rate of associated anomalies detected exclusively at MRI is lower than previously reported in 
fetuses with corpus callosum agenesis undergoing neurosonography. MRI is crucial in detecting 
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INTRODUCTION
The corpus callosum is the largest commissure in the central nervous system (CNS) with a 
cardinal role in the execution of physical, cognitive and affective functions.1-4 Developmental 
defects of the corpus callosum, including either complete (cACC) or partial (pACC) agenesis, 
hypoplasia or dysplasia are among the most common CNS anomalies diagnosed during fetal life. 
Postnatally, the prevalence of callosal defects ranges from 1.8 per 10 000 in the general population 
to 230–600 per 10 000 in children with neurodevelopmental disabilities.2-3,5
Agenesis of corpus callosum (ACC) is a heterogeneous condition that can either be caused by 
chromosomal, infectious, vascular or toxic disorders.3 Chromosomal anomalies can be found in 
5% of children with isolated ACC,2 but in up to 18% of fetuses when ACC is associated with other 
CNS and extra-CNS anomalies, and are the main determinant of postnatal outcome in children 
affected by these anomalies. 4-6 
Prenatal screening for cACC is mainly based upon indirect signs including absence of the 
cavum septi pellucidi (CSP), abnormalities of the lateral ventricles and widening of the 
interhemispheric fissure, while its confirmation requires the lack of visualization of the CC in a 
sagittal view of the fetal brain. Prenatal diagnosis of pACC is much more challenging and many of 
the indirect signs found in fetuses with cACC may be missing.
In the last few years, fetal magnetic resonance imaging (MRI) has been claimed to play an 
important role in detecting additional fetal brain anomalies, and some studies suggest with a 
significantly higher accuracy than ultrasound.7A recent sub-analysis of the MERIDIAN study, a 
large prospective study assessing the role of fetal MRI in detecting associated anomalies in fetuses 
with CNS malformations, reported  that the diagnostic accuracy for detecting ACC as a distinct 
entity was only 40.0% for ultrasound and 92.7% for MRI.8 
However, this study did not describe the imaging protocol adopted for ultrasound 
examination. We have recently reported that, in fetuses with isolated ventriculomegaly, the rate of 
additional anomalies found exclusively at fetal MRI was significantly lower than previously 
reported when a state-of-the-art multiplanar assessment of the fetal brain (neurosonogram) was 
performed.9-11
The primary aim of this systematic review was to report on the role of fetal MRI in 
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to elucidate the rate of additional anomalies detected at MRI according to gestational age at scan 
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 MATERIAL AND METHODS
Protocol, eligibility criteria, information sources and search
This review was performed according to an a priori designed protocol recommended for 
systematic reviews and meta-analysis.12-14 Medline, Embase and Cochrane databases were 
searched electronically in June 2018 and the search was updated in April 2020, utilizing 
combinations of the relevant medical subject heading (MeSH) terms, key words, and word 
variants for “magnetic resonance imaging” and “corpus callosum” (Supporting Information Table 
S1 and S2). Reference lists of relevant articles and reviews were hand searched for additional 
reports. Prisma and MOOSE guidelines were followed.15-17 The study was registered with the 
PROSPERO database (Registration number: CRD42018107284).
Inclusion criteria, outcomes´ measures and study selection
Only studies reporting on fetuses with a prenatal confirmed diagnosis of corpus callosum 
anomalies on ultrasound with no associated structural anomalies, undergoing prenatal MRI were 
included. To be included, a neurosonography (according to International Society of Ultrasound in 
Obstetrics & Gynecology (ISUOG) guidelines) or a brain assessment by a fetal medicine specialist 
(therefore likely to be multiplanar) had to performed. The primary outcome was the rate of 
additional anomalies detected on prenatal MRI. For the purpose of the analysis, we divided the 
population of fetuses affected by corpus callosum anomalies into two groups:
1. Complete agenesis of the corpus callosum 
2. Partial agenesis of the corpus callosum, as defined by authors of the primary study. 
We decided to consider complete and partial agenesis separately because they represents two 
different conditions potentially reflecting different etiologies, since partial agenesis may be due 
not only to arrest in development but also to disruptive events according to which part is missing. 
The secondary outcome was the rate of additional anomalies detected according to the type 
of ultrasound assessment (multiplanar neurosonography vs basic brain assessment), gestational 
age at MRI (24 compared to >24 weeks of gestation) and the rate of anomalies detected 
exclusively at the time of postnatal brain imaging (either ultrasound or MRI).
Anomalies were categorized as:
 Posterior fossa anomalies, including all defects involving the cerebellar vermis and/or 
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 Intra-ventricular hemorrhage 
 Cortical anomalies, including all abnormalities associated with a primary defect in 
neuronal migration towards the cortical surface of the brain
 Periventricular heterotopia




 Complex brain anomalies including all defects characterized by the presence of multiple 
intra-cranial anomalies
 Other cerebral anomalies
Only studies reporting the prevalence of brain anomalies diagnosed on prenatal MRI in fetuses 
affected by isolated ACC were considered eligible for the inclusion in the present systematic 
review. For the ascertainment of the primary and secondary outcomes, we did not consider as 
associated anomalies dimensional increase in the brain structures, such as ventriculomegaly or 
mega cisterna magna or findings typically associated with ACC such as colpocephaly, widening of 
the interhemispheric space, an abnormal course of the pericallosal artery or an abnormal sulcation 
pattern.
Studies including cases with fetal anomalies were excluded in view of the higher risk of 
associated brain anomalies in cases presenting with additional anomalies. Likewise, studies not 
specifying whether fetuses were segregated by complete or partial agenesis of the corpus callosum 
were not considered eligible for the inclusion. Case reports, conference abstracts and case series 
with fewer than 3 cases were excluded to avoid publication bias. Furthermore, studies published 
before 2000 were not included as advances in prenatal imaging make them less relevant.
Two authors (FGS, DDM) reviewed all abstracts independently. Agreement regarding 
potential relevance was reached by consensus; full text copies of those papers were obtained, and 
the same two reviewers independently extracted relevant data regarding study characteristics and 
pregnancy outcome. Inconsistencies were discussed by the reviewers and consensus reached or by 
discussion with a third author (FDA). If more than one study was published on the same cohort 
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population was included to avoid overlapping populations. We contacted the authors of those 
studies where information needed for the review was not presented in the article, but likely to have 
been recorded initially. 
Quality assessment of the included studies was performed using the Newcastle-Ottawa 
Scale (NOS) for cohort studies. According to NOS, each study is judged on three characteristics: 
the selection of the study groups, the comparability of the groups, and the ascertainment of the 
outcome of interest.18 According to NOS a study can be awarded a maximum of one star for each 
numbered item within the Selection and Outcome categories. A maximum of two stars can be 
given for Comparability.18
Statistical analyses
First, we performed random-effect meta-analyses of proportions to estimate the pooled 
rates of each brain anomaly in fetuses affected by isolated ACC on ultrasound undergoing MRI 
assessment. For the purpose of the analysis, we compute this outcome in the overall population of 
fetuses with ACC and in those undergoing dedicated neurosonography and standard assessment of 
fetal brain. Second, we aimed to use random-effect head-to-head meta-analyses to directly 
compare the risk of detecting an associated anomaly in fetuses undergoing early (24 weeks) 
compared to late (>24 weeks) fetal MRI, expressing the results as summary odds ratio (OR) and 
relative 95% confidence interval (CI), and evaluating the statistical heterogeneity through I2 
metric.19 Finally, a sub-group analysis including only fetuses with isolated ACC and no associated 
chromosomal or genetic anomalies was also performed.
Publication bias was assessed graphically through funnel plots and formally through 
Egger's regression asymmetry test20; formal tests for funnel plot asymmetry were not performed 
when the total number of publications included for each outcome was <10 because the power of 
the test is too low to distinguish chance from real asymmetry.21 RevMan 5.3 (The Cochrane 
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General characteristics
Five hundred and forty articles were identified, 109 were assessed with respect to their eligibility 
for inclusion and 14 studies were included in the systematic review (Table 1, Figure 1, Supporting 
Information Table S1)22-35.  These 14 studies included 798 fetuses, of which 258 were affected by 
isolated ACC, defined as either complete or partial absence of the CC with no additional 
anomalies on ultrasound. The definition of isolated ACC was based upon multiplanar 
neurosonography in seven studies (460 fetuses), while a standard sonographic assessment of fetal 
brain was undertaken in the remaining seven studies (338 fetuses).  The majority of MRI 
examinations were performed after 24 weeks of gestation, both for those fetuses undergoing 
neurosonography and those having standard assessment of the fetal brain.  
The results of the quality assessment of the included studies are presented in Table 2. Most of the 
included studies showed a good overall score. The main weaknesses of the studies were their 
retrospective design, small sample size, and different gestational ages at examination; furthermore, 
we could not perform any meaningful sub-analysis according to the gestational age at scan due to 
the paucity of these data.
Complete ACC
Twelve studies22-32,34-35(178 fetuses) explored the role of fetal MRI in detecting associated 
anomalies in fetuses with a prenatal diagnosis of isolated complete ACC on ultrasound. Overall, 
MRI detected 10.9% (95% CI 4.1-20.6) of fetal anomalies not detected on ultrasound, while the 
rate of additional anomalies detected only at birth and missed also at prenatal MRI was 4.3% (95% 
CI 1.4-8.8) (Table 3). However, when stratifying the analysis according to the type of ultrasound 
assessment, the rate of associated anomalies detected only on MRI was 5.7% (95% CI 0.5-16.0) 
when dedicated neurosonography was performed and 18.5% (95% CI 7.8-32.4) in cases 
undergoing a standard assessment of fetal brain (Table 3). The rate of additional anomalies 
detected exclusively at MRI was even lower when considering fetuses with isolated ACC and no 
associated genetic or chromosomal anomalies, with no additional defects found at MRI in this sub-
group of fetuses (PP: 0%, 955 CI 0-17.0; I2: 0%), although this analysis was affected by the very 
small number of included cases.
When stratifying the analysis according to the type of anomaly, the majority of additional 
findings missed at ultrasound and detected only at MRI were cortical anomalies in 6.3% (95% CI 
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in 3.3% (95% CI 0.8-7.3) and posterior fossa anomalies in 2.8% (95% CI 0.9-5.7) of cases. There 
were no cases of hemorrhage or destructive brain anomalies (Table 4).
Finally, additional anomalies also missed at fetal MRI and only detected on postnatal 
imaging were cortical anomalies in 3.1% (95% CI 0.7-7.1) and hemorrhage in 2.9% (95% CI 0.6-
6.8) of cases (Table 4).
Unfortunately, due the very small number of included cases we could not perform a 
comprehensive analysis between early (<24 weeks of gestation) and late (>24 weeks) MRI. 
Partial ACC
Ten studies22-24,27-31,33-34 (35 fetuses) explored the role of fetal MRI in detecting associated 
anomalies in fetuses with a prenatal diagnosis of isolated partial ACC on ultrasound. Overall, MRI 
detected 13.4% (95% CI 4.0-27-0) of fetal anomalies not detected on ultrasound, while the rate of 
additional anomalies detected only postnatally and missed at prenatal MRI was 16.2% (95% CI 
5.9-30-3) (Table 5). However, when stratifying the analysis according to the type of ultrasound 
assessment, the rate of associated anomalies detected only on MRI was 11.4% (95% CI 2.7-25-0) 
when dedicated neurosonography was performed and 16.9% (95% CI 1.3-44-8) in cases 
undergoing a basic assessment of fetal brain (Table 5). The rate of additional anomalies detected 
exclusively at MRI was even lower when considering fetuses with isolated ACC and no associated 
genetic or chromosomal anomalies, with no additional defects found at MRI in this sub-group of 
fetuses (PP: 0%, 955 CI 0-33.7; I2: 0%), although this analysis was affected by the very small 
number of included cases.
When stratifying the analysis according to the type of anomaly, the majority of additional 
findings missed at ultrasound and detected only at MRI were cortical anomalies in 9.3% (95% CI 
2.4-20.1) of cases, followed by posterior fossa anomalies in 7.6% (95% CI 1.6-17.7) of cases and 
complex anomalies in 7% (95% CI 1.2-16.8) of cases. There were no cases of periventricular 
heterotopia, hemorrhage or destructive brain anomalies (Table 6).
Finally, additional anomalies missed at prenatal MRI and detected only postnatally were 
periventricular heterotopia in 10.9% (95% CI 1.9-25.8), cortical anomalies in 8.9% (95% CI 1.8-
20.6) and destructive brain anomalies in 7.9% (95% CI 1.3-19-2) of cases (Table 6).
Unfortunately, due the very small number of included cases we could not perform a 
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DISCUSSION
The findings from this systematic review show that, in fetuses affected by isolated ACC, 
the rate of associated anomalies detected exclusively at MRI was about 11%. This is lower than 
what was previously reported.8 The added benefit of MRI was even lower when a dedicated 
neurosonogram was performed, with only ~5% of fetuses showing additional anomalies at MRI. 
The most common anomalies missed at ultrasound and diagnosed only at fetal MRI were cortical 
and posterior fossa anomalies as well as periventricular heterotopia. This highlights the utility of 
MRI assessment in view of the fact that such undetected anomalies at ultrasound can significantly 
impact the postnatal outcome of these children. Cortical anomalies and heterotopia were also 
among the most common abnormalities missed at fetal MRI and detected only after birth. 
As we here performed a meta-analysis of multiple studies, we were able to gather 
information on an important number of fetuses with isolated ACC. The validity of our study is 
nevertheless limited by the quality of the original studies, which all had a retrospective design, a 
small sample size and were heterogeneous in gestational age at ultrasound and MRI assessment. 
The interval between ultrasound and MRI was not specified23-25,27-31,34  or varied markedly across 
studies, ranging between 14 days26,32,34-35  to more than 4 weeks 22 and therefore the role of MRI 
might have been overestimated due to the evolutive nature of some abnormalities (such as 
heterotopias) rather than the imaging method used for detecting them. 
Another possible limitation was the incomplete reporting of characteristics that could 
potentially influence diagnostic performance of ultrasound. Only seven studies clearly stated that 
ultrasound assessment included neurosonography22-25,27,30,33 while in the remaining no information 
on ultrasound imaging protocol could be extracted26,28-29,31-32,34-35. Nonetheless we assumed that, 
since a classification of the anomaly in complete or partial ACC was available, the assessment 
included at least a mid-sagittal view of the brain. 
Another possible limitation of the study is that we accepted authors' definition of partial 
agenesis of corpus callosum; although we are aware that there might be a wide discrepancy among 
studies, we made this choice because of the small number of fetuses with pACC.
Furthermore, not all cases presenting additional anomalies on MRI were screened for aneuploidies 
or infection, so that it might be entirely possible that some cases affected by aneuploidies or 
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To our knowledge, three systematic reviews have tried to address the additional value of 
fetal MRI when a CNS abnormality is suspected on ultrasound, but none of them specifically 
focused on ACC anomalies. 7,36-37   
In a systematic review of 27 studies including 1184 fetuses with suspected brain 
abnormalities on neurosonography, additional anomalies were found at fetal MRI in 19% of 
cases.36 A high disagreement between ultrasound and MRI was also reported in another systematic 
review of 13 studies including 710 fetuses with a CNS anomaly, in which MRI detected additional 
anomalies in 22% of cases.7 Finally, a recent systematic review including 959 fetuses from 34 
studies reported that disagreement between ultrasound and MRI was 24% when assessing midline 
anomalies, mainly due to missed or wrong interpretations at ultrasound. However, the authors did 
not perform a subgroup analysis on ACC alone, and therefore midline anomalies involved also 
included holoprosencephaly and absent cavum septum pellucidi.37 More importantly, these 
reviews did not take into account whether the type of ultrasound assessment (standard vs 
neurosonography) affected the rate of additional anomalies found exclusively at MRI. 
Isolated ACC, either complete or partial, represents an important clinical challenge for 
maternal fetal specialists affecting both counseling and diagnostic work-up.  The presence of 
associated anomalies is one of the main determinants of postnatal outcomes in children affected by 
these anomalies. Impaired neurocognitive outcome has been shown to affect about 45% of 
children with associated anomalies, although several degrees of disorders of motor control, 
coordination, language, and cognitive status have been described also in children with of isolated 
ACC.2-3 The potential impact of associated anomalies in determining the outcome of children with 
ACC highlights the need for a thorough ultrasound assessment of fetuses with ACC but also 
questions on how prenatal imaging is able to diagnose truly isolated cases of ACC at mid-
gestation.
Some anomalies may appear only later in gestation, and this may have a huge impact on 
short- and long-term prognosis, which should be mentioned during prenatal counseling.
In 2017, a large prospective, multicenter study involving 16 centers across the United Kingdom 
(the MERIDIAN Study) showed that additional anomalies detected exclusively at MRI were 
found in nearly 14% of fetuses with failed commensuration diagnosed at ultrasound, and these 
results had a significant impact on clinical management in over 44% of cases.8
The results from this study support our previous findings on the diagnostic accuracy of 
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need of a detailed multiplanar assessment of fetal brain, as suggested by ISUOG 2007 guidelines, 
in case of suspected CNS structural defect.11,38 Despite this, undetected anomalies at ultrasound 
remain and these include posterior fossa and cortical malformations, which are associated with 
poor short- and long-term neurodevelopmental outcome. This highlights the crucial role of 
prenatal MRI in determining the prognosis of fetuses affected by apparently isolated ACC. This is 
particular important for those couples that want to have the most comprehensive prenatal 
information in order to make the most conscious choice about the future of their pregnancy. 
For couple not considering termination as an option for their pregnancy, we do not 
advocate the need of a fetal MRI since this is unlikely to make a difference for the couple and 
imaging can be postponed after birth. The role of fetal MRI is however challenging also for 
patients uncertain about the future of their pregnancy: while additional abnormalities detected only 
on MRI implies an increased likelihood of neurological impairment after birth4, the absence of 
them cannot be of total reassurance since 4% of fetuses with isolated cACC and 16% of those with 
pACC showed additional anomalies at postnatal imaging. 
Timing of fetal MRI represent another peculiar issue. Currently, there is no convincing 
evidence whether to perform MRI in early second trimester (22-24 weeks) or later in gestation 
(28-30 weeks), but it is common clinical practice to delay fetal MRI in pregnancies with suspected 
fetal brain anomalies, as some malformations can become evident only later on during pregnancy. 
In the present systematic review, it was not possible to stratify the data according to gestational 
age at MRI; however, in a recent large multicenter, MRI performed at or after 24 weeks was an 
independent factor for the detection of additional anomalies missed at ultrasound in fetuses with 
ventriculomegaly detected exclusively. This is not surprising, as the most common anomalies 
detected only at MRI in this study were hemorrhage and migration disorders, that frequently occur 
after the second trimester of pregnancy.39 
Estimation of how prenatal imaging is able to confidently confirm isolated ACC at 
midgestational is fundamental as it would allow parents to undertake a more conscious decision on 
their pregnancy, especially in countries in which termination of pregnancy is not allowed after 24 
weeks of gestation. Unfortunately, the very small number of cases available for the analysis did 
not allow a comprehensive estimation on how early MRI can confidently confirm isolated ACC 
before 24 weeks of gestation. In this scenario, prenatal counselling should stress the fact that a 
proportion of fetuses with a prenatal diagnosis of isolated ACC confirmed at MRI in the second 
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CONCLUSION
The rate of associated anomalies detected exclusively at MRI in fetuses with isolated ACC 
undergoing neurosonography is lower compared to what has been previously reported in studies 
not reporting a clear imaging protocol. Cortical and posterior fossa anomalies are among the most 
common anomalies detected exclusively at MRI, thus confirming the crucial role of prenatal MRI 
in determining the prognosis of fetuses affected by these anomalies. Despite fetal MRI, some 
anomalies can still only be detected postnatally and this should be stressed during parental 
counselling. 
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Legends tables and figure
Table 1. General characteristics of the studies included in the systematic review.
Footnote: GA, gestational age; MRI, magnetic resonance imaging; US, ultrasound; ACC, agenesis of corpus callosum; 
cACC, complete agenesis of corpus callosum; pACC: partial agenesis of corpus callosum.
Table 2. Quality assessment of the included studies according to Newcastle-Ottawa Scale (NOS) 
for cohort studies; a study can be awarded a maximum of one star for each numbered item within 
the Selection and Outcome categories. A maximum of two stars can be given for Comparability.
Table 3. Pooled proportions for the rate of additional anomalies detected only at MRI and post-
natal imaging in fetuses with isolated complete agenesis of corpus callosum .
Table 4. Pooled proportions for the rate of additional anomalies detected only at MRI and post-
natal imaging in fetuses with isolated partial agenesis of corpus callosum.
Table 5. Pooled proportions for the rate of different additional anomalies detected only at MRI in 
fetuses with isolated complete and partial agenesis of corpus callosum.
Table 6. Pooled proportions for the rate of different additional anomalies missed also at MRI and 
detected only at post-natal imaging in fetuses with isolated complete and partial agenesis of corpus 
callosum.
Figure 1. Systematic review flowchart. USS, ultrasound; MRI, magnetic resonance imaging; ACC, 
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Table S1. Excluded studies and reason for the exclusion.
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Table 1. General characteristics of the studies included in the systematic review. 
 







US assessment Callosal anomaly Fetuses Isolated 
ACC 
Turkyilmaz22 2019 Turkey Retrospective 2012-2017 28.6 (+/- 4.1) 4.1±3.3 1.5 Neurosonography cACC, pACC 36 20 
Santirocco23 2019 Spain Retrospective 2007-2015 28-34 weeks NS 1.5 Neurosonography cACC, pACC 86 37 
Masmejan24 2019 Canada Retrospective 2008-2018 NS NS 1.5 Neurosonography cACC, pACC 135 19 
deWit25 2017 The Netherlands Retrospective 2008-2015 25 (22-33) NS 1.5 Neurosonography cACC 25 8 
Griffiths26 2017 United Kingdom Prospective 2011-2014 >18 weeks  within 14 
days 
1.5 NS aCC 79 55 
Ruland27 2015 Germany Retrospective 1999-2012 NS NS NS Neurosonography cACC, pACC  140 41 
Özyüncü28 2014 Turkey Retrospective 2002-2012 NS NS 1,5 NS cACC, pACC 33 7 
Kasprian29 2013 Austria Prospective NS 27.6 +/- 6.1 NS 1.5 NS cACC, pACC 20 13 
Ghi30 2010 Italy Retrospective 1998 - 2008 NS NS 1.5 Neurosonography pACC 19 4 
Fratelli31 2007 United Kingdom Retrospective 1993-2003 26.8 NS 1.5 NS cACC 129 35 
Rickard32 2006 United Kingdom Retrospective 1999 - 2004  26.5 (20-35) Within 4 
days 
1.5 NS  40 5 
Volpe33 2006 Italy Retrospective 1996-2005 21-34 NS NS Neurosonography pACC 19 5 




1.5 NS cACC, pACC 10 1 
Ismail35 2002 United Kingdom Retrospective 1998-2001  27.52 (21–34) Within 10 
days 
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Table 2. Quality assessment of the included studies according to Newcastle-Ottawa Scale (NOS) for 
cohort studies; a study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability. 
 
Author Year Selection Comparability Outcome 
Turkyilmaz
22
 2019   
Santirocco
23
 2019   
Masmejan
24
 2019   
deWit
25
 2017   
Griffiths
26
 2017   
Ruland
27
 2015   
Özyüncü
28
 2014   
Kasprian
29
 2013   
Ghi
30
 2010   
Fratelli
31
 2007   
Rickard
32
 2006   
Volpe
33
 2006   
Glenn
34
 2005   
Ismail
35
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Table 3. Pooled proportions for the rate of additional anomalies detected only at MRI and post-natal 
imaging in fetuses with isolated complete ACC. 
 






 Pooled proportions 
(95% CI) 
All fetuses with cACC 
Associated anomalies at 
fetal MRI 
12 22/178  62.2 10.92 (4.1-20.6) 
Associated anomalies at 
post-natal imaging 
9 4/108  3 4.31 (1.4-8.8) 
Fetuses with cACC undergoing neurosonography 
Associated anomalies at 
fetal MRI 
5 6/95  63.6 5.67 (0.5-16.0) 
Fetuses with cACC undergoing standard US assessment
*
 
Associated anomalies at 
fetal MRI 
7 16/83  30 18.47 (7.8-32.4) 
cACC, complete agenesis of corpus callosum; MRI, magnetic resonance imaging; US, ultrasound. 
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Table 4. Pooled proportions for the rate of additional anomalies detected only at MRI and post-natal 
imaging in fetuses with isolated partial ACC. 
 






 Pooled proportions 
(95% CI) 
All fetuses with pACC 
Associated anomalies at 
fetal MRI 
10 4/35  16.6 13.36 (4.0-27.0) 
Associated anomalies at 
post-natal imaging 
8 4/28  22.9 16.16 (5.9-30.3) 
Fetuses with pACC undergoing neurosonography 
Associated anomalies at 
fetal MRI 
6 3/27  43.1 11.39 (2.7-25.0) 
Fetuses pACC undergoing standard US assessment
*
 
Associated anomalies at 
fetal MRI 
4 1/8  0 16.91 (1.3-44.8) 
pACC, partial agenesis of corpus callosum; MRI, magnetic resonance imaging; US, ultrasound. 
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Table 5. Pooled proportions for the rate of different additional anomalies detected only at MRI in 
fetuses with isolated complete and partial ACC. 
 






 Pooled proportions 
(95% CI) 
cACC 
Associated anomalies at 
fetal MRI 
12 22/178  62.2 10.92 (4.1-20.6) 
Posterior fossa 
anomalies 
12 3/178  0  2.84 (0.9-5.7) 
Cortical anomalies 12 11/178  8.4  6.28 (3.0-10.6) 
Heterotopia 12 4/178  0 3.51 (1.3-6.6) 
Hemorrhage 12 0/178  0 0 (0-3.4) 
Destructive brain 
anomalies 
12 0/178  0 0 (0-3.4) 
Complex anomalies 12 4/178  24.6 3.25 (0.8-7.3) 
pACC 
Associated anomalies at 
fetal MRI 
10 4/35  16.6 13.36 (4.0-27.0) 
Posterior fossa 
anomalies 
10 1/35  0 7.63 (1.6-17.7) 
Cortical anomalies 10 2/35  0 9.29 (2.4-20.1) 
Heterotopia 10 0/35  0 0 (0-14.6) 
Hemorrhage 10 0/35  0 0 (0-14.6) 
Destructive brain 
anomalies 
10 0/35  0 0 (0-14.6) 
Complex anomalies 10 1/35  0 6.96 (1.2-16.8) 
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Table 6. Pooled proportions for the rate of different additional anomalies missed also at MRI and 
detected only at post-natal imaging in fetuses with isolated complete and partial ACC. 
 






 Pooled proportions 
(95% CI) 
cACC 
Associated anomalies at 
post-natal MRI 
9 4/108  3 4.31 (1.4-8.8) 
Posterior fossa 
anomalies 
9 0/108  0 0 (0-4.9) 
Cortical anomalies 9 2/108  0 3.11 (0.7-7.1) 
Heterotopia 9 0/108  0 0 (0-4.9) 
Hemorrhage 9 2/108  0 2.89 (0.6-6.8) 
Destructive brain 
anomalies 
9 0/108  0 0 (0-4.9) 
Complex anomalies 9 0/108  0 0 (0-4.9) 
pACC 
Associated anomalies at 
post-natal  MRI 
8 4/28  22.9 16.16 (5.9-30.3) 
Posterior fossa 
anomalies 
8 0/28  0 0 (0-16.1) 
Cortical anomalies 8 1/28  0 8.86 (1.8-20.6) 
Heterotopia 8 2/28  21.3 10.90 (1.9-25.8) 
Hemorrhage 8 0/28  0 0 (0-16.1) 
Destructive brain 
anomalies 
8 1/28  0 7.89 (1.3-19.2) 
Complex anomalies 8 0/28  0 0 (0-16.1) 
cACC, complete agenesis of corpus callosum; pACC, partial agenesis of corpus callosum; MRI, magnetic resonance imaging.  
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